Le Lézard
Classified in: Mining industry, Health, Covid-19 virus
Subject: TDS

Selecting the Fast Path in Diagnostics Manufacturing Without Sacrificing Performance, Upcoming Webinar Hosted by Xtalks


TORONTO, Nov. 25, 2020 /PRNewswire-PRWeb/ -- Before the advent of COVID-19, medical professionals reported running over 2 billion rapid diagnostic tests globally per year. Even in the pre-COVID era, the need to have speed to market in manufacturing with each new diagnostic technology was essential for diagnostic supply companies to ensure market share and supply chain continuity.

With the advent of SARS-CoV-2, the virus that causes COVID-19, public health officials anticipate the need for as many as 300 million tests per month in each the US and EU, increasing demand for diagnostic tests by a factor of ten over the coming years. With such demands, launching new technologies and products is even more urgent. The need for speed in manufacturing launch and efficiency with robust processing in production are critical components in bringing diagnostic tests, whether for COVID-19 or other health conditions, to market promptly and meet the supply chain demands. While most product launches use new, novel or updated technologies with unique configurations, the key aspects of manufacturing remain the same.

Speed to manufacturing launch is key for market share. Speed and efficiency, once in production, are key for supply and continued inventory. However, merely going fast does not mean just using faster equipment or getting the right supplier. In this webinar, the featured speaker will discuss how design, manufacturing strategy, and key technology partners are the cornerstone of achieving accelerated launch of diagnostic products and maintaining the production efficiency, quality and delivery that the market both needs and desires.

Join David Wolgemuth, Molding & Manufacturing Technology Specialist, Phillips-Medisize, in a live webinar on Friday, December 11, 2020 at 1pm EST.

For more information, or to register for this event, visit Selecting the Fast Path in Diagnostics Manufacturing Without Sacrificing Performance.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Sydney Perelmutter, Xtalks, +1 (416) 977-6555 x 352, [email protected]

 

SOURCE Xtalks


These press releases may also interest you

15 avr 2024
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against QuidelOrtho ("QuidelOrtho" or "the Company") and certain of its officers....

15 avr 2024
Tampa General Hospital (TGH) today celebrated more than $120 million in charitable contributions over a two-year period to advance its vision to transform health care through innovation. The latest gift toward the $120 million milestone came from the...

15 avr 2024
The acceleration of digital transformations and cloud implementations by Australian companies and government agencies is expanding the country's Microsoft cloud ecosystem, according to a new research report published today by Information Services...

15 avr 2024
TSX-V:  CWV: Crown Point Energy Inc. ("Crown Point", the "Company", "we" or "our") is pleased to provide an update on the status of its proposed acquisition of a 100% working interest in the Piedra Clavada and Koluel Kaike hydrocarbon exploitation...

15 avr 2024
Acadia Realty Trust (the "Company") announced today that it closed on a $750 million amended and restated credit facility, which replaces and extends the Company's existing $700 million credit facility. The facility was oversubscribed and maintained...

15 avr 2024
Roth CH Acquisition Co. ("we", "us", "our", or the "Company"), today announced that it has notified the Nasdaq Stock Market LLC ("Nasdaq") of its decision to voluntarily delist its Class A Ordinary Shares, Units and Warrants exercisable for one...



News published on and distributed by: